Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020.

ABSTRACT:

Background

The aim of this study was to evaluate the health and economic impact of the varicella vaccination program on varicella disease in the United States (US), 1996-2020.

Methods

Analysis was conducted using the Centers for Disease Control and Prevention or published annual population-based varicella incidence, and varicella-associated hospitalization, outpatient visit, and mortality rates in the US population aged 0-49 years during 1996-2020 (range, 199.5-214.2 million persons) compared to before vaccination (1990-1994). Disease costs were estimated using the societal perspective. Vaccination program costs included costs of vaccine, administration, postvaccination adverse events, and travel and work time lost to obtain vaccination. All costs were adjusted to 2020 US do

SUBMITTER: Zhou F 

PROVIDER: S-EPMC10941259 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature